Cannabis investments are difficult enough when the investor is a U.S.-based person or entity. But things can get immensely more complicated when foreign investment is on the table. Today I want to highlight some of the top considerations for foreign investors and U.S. cannabis companies alike. 1. Legality could cause serious headaches To this day,
Australia is said to have one of the highest cannabis prevalence rates in the world and public attitudes to its use are shifting. North American, European and other cannabis companies looking for investment opportunities would do well to follow these shifts. Growing cannabis for medicinal and scientific purposes was legalized under federal law in 2016.
Two of our international cannabis lawyers, Vince Sliwoski (business) and Adams Lee (international trade), recently joined the Simply Trade podcast for a lively discussion on the international cannabis trade. You can hear that free-ranging, informative conversation at either of the following links: Apple Podcasts Spotify As explained in the Simply Trade show notes: This episode
We are seeing in an uptick in China-related matters involving cannabis brands. Here are three tips for cannabis brands that are getting their products made in China: 1. Sign a Contract As I recently wrote in our sister blog, “while having a contract provides no guarantee of smooth operations or favorable dispute resolution, a well-drafted
Cannabis Brands and China Challenges Cannabis brands account for a sizeable component of my law firm’s intellectual property work (and, indeed, our work generally). Historically, there has been little overlap between our cannabis and China practice areas, beyond our representing a number of cannabis ancillary product companies on their China manufacturing matters. This is starting to change,
Germany has taken an important step toward cannabis legalization, with the release by the Health Ministry of the draft Cannabis Act (Cannabisgesetz or CanG). According to the Ministry, the bill seeks “to legalize private cultivation by adults for personal consumption as well as communal, non-commercial cultivation of cannabis in cultivation associations.” For more information on
We’ve recently received a number of inquiries about whether it is legal to import marijuana seeds into the United States. These are seeds derived from marijuana plants that have a THC content less than 0.3%, but when planted will germinate into marijuana plants that have a THC content more than 0.3%. The seeds themselves have
European Union member states tend to be very conservative when it comes to cannabis legalization. With a few exceptions, most member states prohibit cannabis altogether. Other countries decriminalize cannabis and a handful have adopted modest medical marijuana programs. Germany, the EU’s biggest economy and arguably most influential nation, has been on the path towards recreational
In the U.S., cocaine is a Schedule II controlled substance and its use, possession, etc. is illegal except for certain, limited medical applications. The licensed sale of cocaine for recreational use is not even remotely a concept in the U.S., and the same goes for Canada. Why then did we see a Canadian cannabis company
Peru has new regulations for the use of medical cannabis, following the issuance of Supreme Decree (Decreto Supremo) No. 004-2023-SA on February 28 of this year. The decree approves the Regulation that Regulates the Medicinal and Therapeutic Use of Cannabis and Its Derivatives (Reglamento que regula el uso medicinal y terapéutico del cannabis y sus
